| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Mar 2026 | 20 Mar 2026 |
| Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2026 inter alia to consider and approve The proposal for raising of funds by way of issue of one or more instruments including equity shares/ convertible securities either by way of Preferential Issue/ Rights Issue/ QIP/ or any other mode as may be considered subject to such approvals as may be required and to transact other businesses Issue and allotment of Fully Convertible Warrants (Warrants), to person(s) belonging to the Promoter & Promoter Group Category and Non-Promoter Category, on a preferential basis, aggregating up to Rs. 21,00,00,000 (Rupees Twenty-One Crores Only), at such issue price as may be determined by the Board/ Committee of Directors in accordance with the provisions of Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. (As Per BSE Announcement Dated on:28.03.2026) | ||
| Board Meeting | 14 Feb 2026 | 6 Feb 2026 |
| Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the Quarter ended 31st December 2025. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we wish to inform you that, the Board of Directors of the Company at its meeting held today i.e. February 14, 2026 has, inter alia, considered and approved the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2025 along with the Limited Review Report. (As Per BSE Announcement Dated on:14.02.2026) | ||
| Board Meeting | 2 Feb 2026 | 2 Feb 2026 |
| Outcome of Board Meeting | ||
| Board Meeting | 12 Nov 2025 | 5 Nov 2025 |
| Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited financial results of the Company for the quarter and half year ended 30th September 2025. Please find attached Outcome of Board Meeting. Please find attached Unaudited Financial Results for the quarter and half year ended 30th September, 2025. (As Per BSE Announcement Dated on:12.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 1 Aug 2025 |
| Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve 1. Unaudited financial results of the Company for the quarter ended 30th June 2025. 2. Draft Directors Report for the financial year ending 31st March 2025. 3. Draft notice convening 33rd Annual General Meeting of the Company. Please find attached Outcome of Board Meeting. Please find attached Unaudited Financial Results for the quarter ended 30th June, 2025. (As Per BSE Announcement Dated on:12.08.2025) | ||
| Board Meeting | 30 May 2025 | 21 May 2025 |
| Final Dividend & Audited Results The Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2025. Intimation under Regulation 30. (As Per BSE Announcement Dated on :30.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
